Version history

{
  "session_id": "sess_SDA-2026-04-08-gap-pubmed-20260406-062128-34a47c4e",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "us.anthropic.claude-sonnet-4-20250514-v1:0",
  "action": "propose",
  "content": "Based on the knowledge gap regarding how complement-mediated synaptic elimination in the hippocampus produces both cognitive deficits and anxiety-like behaviors, here are my novel therapeutic hypotheses:\n\n## Hypothesis 1: Circuit-Specific Complement Targeting\n**Description:** Different hippocampal circuits (CA1-prefrontal for cognition vs CA3-amygdala for anxiety) express distinct complement receptor profiles, making them differentially vulnerable to C1q/C3-mediated elimination. Selective complement inhibition could preserve cognitive circuits while allowing anxiety-related synaptic pruning to normalize emotional regulation.\n\n**Target:** C1q complement protein with circuit-specific delivery systems\n\n**Supporting Evidence:** The source paper (PMID:36600274) demonstrates complement-mediated synaptic elimination affecting both phenotypes, suggesting spatial heterogeneity in vulnerability patterns.\n\n**Confidence:** 0.75\n\n## Hypothesis 2: Microglial State-Dependent Synapse Selection\n**Description:** Activated microglia exist in multiple polarization states that selectively target different synapse types - M1-like states preferentially eliminate excitatory synapses (causing cognitive deficits) while M2-like states target inhibitory synapses (causing anxiety). Modulating microglial polarization could dissociate these behavioral outcomes.\n\n**Target:** TREM2 and CD68 microglial activation markers\n\n**Supporting Evidence:** PMID:36600274 shows microglial involvement in synaptic elimination, and different microglial states are known to have distinct phagocytic preferences.\n\n**Confidence:** 0.80\n\n## Hypothesis 3: Synaptic Tagging Differential Vulnerability\n**Description:** Cognitive and anxiety-related synapses display different \"eat-me\" signals (phosphatidylserine, calreticulin) making them selectively vulnerable to complement-mediated elimination. Therapeutically masking these signals could provide phenotype-specific neuroprotection without global immunosuppression.\n\n**Target:** Phosphatidylserine and calreticulin synaptic exposure\n\n**Supporting Evidence:** The behavioral dissociation in PMID:36600274 suggests distinct molecular mechanisms underlying selective synaptic vulnerability.\n\n**Confidence:** 0.70\n\n## Hypothesis 4: Astrocytic Complement Regulation Hypothesis\n**Description:** Reactive astrocytes differentially regulate local complement activity through region-specific expression of complement inhibitors (CD55, CD46). Enhancing astrocytic complement control in cognitive regions while maintaining it in emotional circuits could prevent cognitive decline while preserving anxiety regulation.\n\n**Target:** Astrocytic CD55 (DAF) and CD46 complement inhibitors\n\n**Supporting Evidence:** PMID:36600274 demonstrates neuroinflammation alongside complement activation, and astrocytes are key regulators of local complement activity.\n\n**Confidence:** 0.65\n\n## Hypothesis 5: Neurotransmitter-Specific Synapse Targeting\n**Description:** Complement preferentially tags synapses based on neurotransmitter identity - cholinergic synapses (memory) vs GABAergic synapses (anxiety inhibition) - due to differential complement receptor expression. Protecting specific neurotransmitter systems could dissociate behavioral phenotypes.\n\n**Target:** Cholinergic (ChAT) and GABAergic (GAD67) synaptic terminals\n\n**Supporting Evidence:** The dual phenotype in PMID:36600274 suggests neurotransmitter-specific vulnerability patterns in hippocampal complement-mediated elimination.\n\n**Confidence:** 0.72\n\n## Hypothesis 6: Temporal Complement Activation Windows\n**Description:** Cognitive and anxiety phenotypes emerge from different temporal phases of complement activation - early C3a/C5a inflammatory signaling causes anxiety through direct neuronal excitation, while delayed C1q-mediated synaptic elimination causes cognitive deficits. Time-specific complement inhibition could selectively prevent each phenotype.\n\n**Target:** C3a/C5a receptors (early) and C1q (delayed)\n\n**Supporting Evidence:** PMID:36600274 shows both neuroinflammation and synaptic elimination, suggesting temporal complexity in complement-mediated pathology.\n\n**Confidence:** 0.78\n\n## Hypothesis 7: Metabolic-Complement Coupling\n**Description:** Anesthesia-induced metabolic stress makes cognitively-active synapses more vulnerable to complement attack through ATP depletion and reduced complement inhibitor production, while anxiety circuits remain metabolically stable. Metabolic support could preferentially protect cognitive synapses from complement-mediated elimination.\n\n**Target:** Mitochondrial Complex I and ATP synthase in hippocampal neurons\n\n**Supporting Evidence:** Prolonged anesthesia in PMID:36600274 likely creates metabolic stress, and complement activation is energy-dependent, suggesting metabolic vulnerability underlies differential phenotypes.\n\n**Confidence:** 0.68\n\nThese hypotheses propose that the same complement-mediated process can generate distinct behavioral outcomes through spatial, temporal, cellular, or molecular specificity mechanisms, providing multiple therapeutic entry points for treating perioperative neurocognitive disorders.",
  "tokens_used": "1289",
  "persona_id": "persona-theorist"
}